← All organizations
Highest phase reached
Phase 3
First clinical trial
May 17, 2019Last known activity
Dec 31, 2023
Acquired by Zymeworks Inc. on Mar 22, 2016
Timeline
2010s
- Jun 1, 2013
Compass Therapeutics— Founded
- Mar 22, 2016
Zymeworks Inc.— Acquired By
Drugs by trial phase (4 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT06150664Lead sponsorPhase 1Dec 31, 2023
- NCT05513742Lead sponsorPhase 2Dec 8, 2022
- NCT05513742Study directorPhase 2Dec 8, 2022
- NCT05506943Lead sponsorPhase 2/Phase 3Sep 30, 2022
- NCT05506943Study directorPhase 2/Phase 3Sep 30, 2022
- NCT03881488Lead sponsorPhase 1May 17, 2019
- NCT03881488Study directorPhase 1May 17, 2019
Details
- Founded
- Vancouver, BC, CA Jun 1, 2013
- Last known activity
- Dec 31, 2023
Notes
formerly Kairos Therapeutics